Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 29, Issue 8, Pages 904-914
Publisher
Springer Nature
Online
2016-05-13
DOI
10.1038/modpathol.2016.88
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
- (2015) Roberta Ferraldeschi et al. EUROPEAN UROLOGY
- Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN
- (2015) Aitziber Ugalde-Olano et al. METHODS
- A multicenter study showsPTENdeletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- (2015) Dean A. Troyer et al. PROSTATE
- TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer
- (2014) Stefan Steurer et al. EUROPEAN UROLOGY
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- (2014) Tamara L Lotan et al. MODERN PATHOLOGY
- Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer
- (2014) Antje Krohn et al. MODERN PATHOLOGY
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Genetic markers associated with early cancer-specific mortality following prostatectomy
- (2013) Wennuan Liu et al. CANCER
- Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
- (2013) B Gumuskaya et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers
- (2012) Sarah Hawley et al. ADVANCES IN ANATOMIC PATHOLOGY
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
- (2012) Emmanuel S. Antonarakis et al. CANCER
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- (2012) Himisha Beltran et al. EUROPEAN UROLOGY
- Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer
- (2012) Tarek A Bismar et al. HISTOPATHOLOGY
- Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
- (2012) Alcides Chaux et al. MODERN PATHOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications
- (2011) Maisa Yoshimoto et al. GENES CHROMOSOMES & CANCER
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
- (2010) Laura Poliseno et al. NATURE
- Identification of the miR-106b 25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation
- (2010) L. Poliseno et al. Science Signaling
- A Robust Immunohistochemical Assay for Detecting PTEN Expression in Human Tumors
- (2010) Zaina Sangale et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
- (2009) Kanishka Sircar et al. JOURNAL OF PATHOLOGY
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Is PTEN loss associated with clinical outcome measures in human prostate cancer?
- (2008) P McCall et al. BRITISH JOURNAL OF CANCER
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started